Event Information

Event Topic:
Value Proposition for Precision Medicine — Case Studies on the front lines

Event Description:
The value proposition for adopting the tools that deliver critical disease information is not widely understood. There are many medical technologies and interventions that are rapidly emerging into clinical practice, and the key for realizing the full value of these new products or techniques will often hinge on the cognitive understanding of the medical problem in the minds of the treatment team as they make decisions in each case. Tools designed to enhance the understanding of the case at a granular level are improving all the time, and incorporating them into drug & device development will lead to much more efficient solutions and vastly better outcomes. We will review a few cases that illustrate these factors and discuss them together.

Date/Time:
Date(s) - 12/14/21
6:15 pm - 8:30 pm

Event Location:
Zoom talk: https://us02web.zoom.us/j/88274227563:

Speaker Information

Event Speaker:
Ted Snelgrove

Event Speaker Title:
Chief Business Officer

Event Speaker Company:
Lexent Bio

Event Speaker Bio:

Ted Snelgrove has 30+ years experience in commercialization of novel products in health care, mostly in the oncology field. He was recently CBO for Lexent Bio, a liquid biopsy company sold to Roche/Foundation Medicine in 2020. Ted has been instrumental in developing and launching molecular diagnostics, driving adoption and reimbursement coverage for proprietary assets that often involve significant disruption in clinical practice. He built the original commercial teams at Genomic Health and Crescendo, and grew the teams at Counsyl & Guardant Health. He also has broad experience with therapeutic and supportive care drugs, having worked at Jazz Pharma, ALZA, Amgen & Eli Lilly. He was a Naval Officer before that and hails from Minneapolis.

Event Details

Cost:
$0

Add To Calendar